These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14718160)

  • 1. Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets.
    Hughes T; Andrews B; Boone C
    Cell; 2004 Jan; 116(1):5-7. PubMed ID: 14718160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yeast as a tool to uncover the cellular targets of drugs.
    Sturgeon CM; Kemmer D; Anderson HJ; Roberge M
    Biotechnol J; 2006 Mar; 1(3):289-98. PubMed ID: 16897709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards high-throughput characterization of small molecule mechanisms of action.
    Luesch H
    Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast.
    Parsons AB; Lopez A; Givoni IE; Williams DE; Gray CA; Porter J; Chua G; Sopko R; Brost RL; Ho CH; Wang J; Ketela T; Brenner C; Brill JA; Fernandez GE; Lorenz TC; Payne GS; Ishihara S; Ohya Y; Andrews B; Hughes TR; Frey BJ; Graham TR; Andersen RJ; Boone C
    Cell; 2006 Aug; 126(3):611-25. PubMed ID: 16901791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics: yeast lead the way.
    Foss E; Bedalov A
    Chem Biol; 2006 Mar; 13(3):236-8. PubMed ID: 16638528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative functional genomics of stress responses in yeasts.
    Lelandais G; Devaux F
    OMICS; 2010 Oct; 14(5):501-15. PubMed ID: 20695825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
    Barros SA
    Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical Medication Development: New Targets and New Drugs.
    Kasten CR; Boehm SL
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1418-24. PubMed ID: 27177689
    [No Abstract]   [Full Text] [Related]  

  • 10. Old drugs, new tricks: update on stroke therapeutics.
    Fagan SC
    Rev Neurol Dis; 2010; 7 Suppl 1():S1-2; quiz S23. PubMed ID: 20410865
    [No Abstract]   [Full Text] [Related]  

  • 11. Yeast chemical genomics and drug discovery: an update.
    Hoon S; St Onge RP; Giaever G; Nislow C
    Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal agents: mode of action in yeast cells.
    Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
    Rev Esp Quimioter; 2006 Jun; 19(2):130-9. PubMed ID: 16964330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the power of the genome in the search for new antibiotics.
    Rosamond J; Allsop A
    Science; 2000 Mar; 287(5460):1973-6. PubMed ID: 10720317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining drug targets in yeast haploinsufficiency screens: application to human translational pharmacology.
    Roberge M
    Sci Signal; 2008 Aug; 1(34):pt5. PubMed ID: 18728306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of gene expression regulatory networks in yeasts.
    Lelandais G; Goudot C; Devaux F
    C R Biol; 2011; 334(8-9):655-61. PubMed ID: 21819947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-scale metabolic models of yeast, methods for their reconstruction, and other applications.
    Bordel S
    Methods Mol Biol; 2014; 1152():269-79. PubMed ID: 24744039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How many drug targets are there?
    Overington JP; Al-Lazikani B; Hopkins AL
    Nat Rev Drug Discov; 2006 Dec; 5(12):993-6. PubMed ID: 17139284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From genetics and genomics to drug discovery: yeast rises to the challenge.
    Melese T; Hieter P
    Trends Pharmacol Sci; 2002 Dec; 23(12):544-7. PubMed ID: 12457767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations.
    Cho MJ; Juliano R
    Trends Biotechnol; 1996 May; 14(5):153-8. PubMed ID: 8645449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.